News shared by:

336 Articles
10 Feb 2019
J&J’s Esketamine for Depression Faces an FDA Panel Next Week

U.S. Food and Drug Administration (FDA) advisory committee will debate whether to recommend Johnson & Johnson’s esketamine spray for major depression. It may...

10 Feb 2019
U.S. pharmaceutical companies fight to prevent lower Canada's drug prices

U.S. pharmaceutical companies are fighting Canada's drug price reforms, which were supposed to take effect last month. (CBC) Offers of voluntary price freezes, backroom meetings with...

08 Feb 2019
GSK signs $4.2bn immunotherapy deal with the Merck

GlaxoSmithKline (GSK) has entered into a global strategic collaboration with the Merck group for an immunotherapy candidate M7824 (bintrafusp alfa) in difficult-to-treat cancers. As part of...

08 Feb 2019
Phillips-Medisize wins Best Innovation at Pharmapack Awards

Phillips-Medisize’s Connected Health Platform (CHP) has won Best Innovation in Drug Delivery at the Pharmapack Awards.  Pharmapack Award Kevin Deane The company’s unified...

06 Feb 2019
Glenmark Pharmaceuticals and Grandpharma Companies Entered into Agreement

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive...

06 Feb 2019
Rebate Challenge Alters Drug Pricing Debate

New HHS proposal would remove the current safe harbor protection from the federal Anti-Kickback Statute for rebates or discounts provided to Medicare Part D drug plans and certain state Medicaid...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×